Trial site
MBAL Dr. Ivan Seliminski Sliven AD
- 10running trials
- 8closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Schizophrenia8 trials
- Asthma2 trials
- Bipolar disorder2 trials
- Atrial fibrillation1 trial
- Chronic kidney disease1 trial
- COPD1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Hepatitis B1 trial
- Sjögren's disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 312 trials
- Phase 25 trials
- Phase 11 trial
- Status
- Completed8 trials
- Recruiting8 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Chiesi Farmaceutici S.p.A.3 trials
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company2 trials
- Neurocrine Biosciences2 trials
- Anthos Therapeutics, Inc.1 trial
- Argenx1 trial
- and 9 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Recruiting
NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Recruiting
Efepoetin alfa for treatment of anemia in chronic kidney disease on dialysis
Recruiting
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Not yet recruiting
Recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Schizophrenia5 recruiting
- Atrial fibrillation1 recruiting
- Bipolar disorder1 recruiting
- Chronic kidney disease1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
A study to assess the efficacy and safety of lumateperone in patients with Bipolar Mania
Completed
Completed
A 52-week, Open-label Trial of CVL-231 in Adult Participants With Schizophrenia
Completed
Completed
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 13 Nov 2026